Search results: Sage Journals

Retricted accessResearch articleFirst published October, 2024

Analysis of composite time-to-event endpoints in cardiovascular outcome trials

Rachel Marceau West, Gregory Golm, Devan V Mehrotra

Clinical Trials

Free accessResearch articleFirst published April 3, 2020

Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson’s Disease

Mariana Alves, Daniel Caldeira, Miguel Leal Rato [...]

Journal of Parkinson’s Disease

Retricted accessResearch articleFirst published March, 2019

Developing,Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark [...]

Therapeutic Innovation & Regulatory Science

Retricted accessResearch articleFirst published December, 2020

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk

Donna Spiegelman, Laura C Lovato, Polyna Khudyakov [...]

European Journal of Preventive Cardiology

Open accessReview articleFirst published 2024

Digital health technologies and artificial intelligence in cardiovascular clinical trials: A landscape of the European space

Fabio Lampreia, Catarina Madeira, Hélder Dores

DIGITAL HEALTH

Open accessResearch articleFirst published 2019

Impact of FDA-Required Cardiovascular Outcome Trials on Type 2 Diabetes Clinical Study Initiation From 2008 to 2017

Cameron M. Kieffer, Andrew S. Robertson

Therapeutic Innovation & Regulatory Science

Retricted accessResearch articleFirst published October, 2010

A randomized clinical trial on n -3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk

Gunnar Einvik, Tor Ole Klemsdal, Leiv Sandvik [...]

European Journal of Preventive Cardiology

Open accessResearch articleFirst published March, 2018

Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study

Jelena Pavlović, Philip Greenland, Jaap W Deckers [...]

European Journal of Preventive Cardiology

Retricted accessResearch articleFirst published August, 2019

Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial

Sabine JAM Denissen, Carlijn M van der Aalst, Marleen Vonder [...]

European Journal of Preventive Cardiology

Open accessResearch articleFirst published April, 2025

The effects of extra virgin olive oil or butter on cardiovascular biomarkers in European and Chinese males in the UK: A pilot randomised crossover trial

Fan Liang, Julie Young, Georgios Koutsidis [...]

Nutrition and Health

Retricted accessResearch articleFirst published October, 2024

Analysis of composite time-to-event endpoints in cardiovascular outcome trials

Rachel Marceau West, Gregory Golm, Devan V Mehrotra

Clinical Trials

Free accessResearch articleFirst published April 3, 2020

Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson’s Disease

Mariana Alves, Daniel Caldeira, Miguel Leal Rato [...]

Journal of Parkinson’s Disease

Retricted accessResearch articleFirst published March, 2019

Developing,Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark [...]

Therapeutic Innovation & Regulatory Science

Retricted accessResearch articleFirst published December, 2020

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk

Donna Spiegelman, Laura C Lovato, Polyna Khudyakov [...]

European Journal of Preventive Cardiology

Open accessReview articleFirst published 2024

Digital health technologies and artificial intelligence in cardiovascular clinical trials: A landscape of the European space

Fabio Lampreia, Catarina Madeira, Hélder Dores

DIGITAL HEALTH

Open accessResearch articleFirst published 2019

Impact of FDA-Required Cardiovascular Outcome Trials on Type 2 Diabetes Clinical Study Initiation From 2008 to 2017

Cameron M. Kieffer, Andrew S. Robertson

Therapeutic Innovation & Regulatory Science

Retricted accessResearch articleFirst published October, 2010

A randomized clinical trial on n -3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk

Gunnar Einvik, Tor Ole Klemsdal, Leiv Sandvik [...]

European Journal of Preventive Cardiology

Open accessResearch articleFirst published March, 2018

Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study

Jelena Pavlović, Philip Greenland, Jaap W Deckers [...]

European Journal of Preventive Cardiology

Retricted accessResearch articleFirst published August, 2019

Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial

Sabine JAM Denissen, Carlijn M van der Aalst, Marleen Vonder [...]

European Journal of Preventive Cardiology

Open accessResearch articleFirst published April, 2025

The effects of extra virgin olive oil or butter on cardiovascular biomarkers in European and Chinese males in the UK: A pilot randomised crossover trial

Fan Liang, Julie Young, Georgios Koutsidis [...]

Nutrition and Health